Atlas Trials

Nolatrexed Dihydrochloride Compared With Doxorubicin in Treating Patients With Recurrent or Unresectable Liver Cancer

Clinical trial NCT00012324 · COMPLETED

Trial details

NCT number
NCT00012324
Sponsor
Eximias Pharmaceutical
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Liver Cancer
Start date
2000-09-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.